Markets
← Back to Stocks
SOLV
SOLVENTUM CORP
Health Care · Health Care Technology
$67.14
-0.19%
Vol: 0.0M
Araverus Market Read
Thursday, March 19, 2026
Solventum 5.38% pre-market plunge weighs on healthcare earnings as Q4 EPS missed 10.29% forecast amid margin compression.
Solventum plunged 5.38% in pre-market to $72.80 and 2.52% in after-hours to $75.00 following Q4 EPS miss of 10.29% ($1.57 vs $1.75 forecast). Revenue reached $2.0B with 3.5% organic growth but gross margin declined 230bps sequentially to 53.5% and operating margin compressed to 19.9%, driven by logistics cost pressures. Stock facing significant headwind from margin deterioration despite topline growth.
Price 50d 200d
Previous Market Reads
2 of 2 days↓
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| LLYELI | $916.83 | -0.13% | -11.4% | 21.8x | 0.43 | $821.2B |
| JNJJOHNSON | $237.56 | +0.16% | -1.8% | 18.9x | 0.33 | $572.6B |
| ABBVABBVIE | $206.31 | -0.97% | -11.4% | 12.8x | 0.33 | $364.6B |
| MRKMERCK | $114.17 | -0.29% | -5.4% | 11.7x | 0.26 | $282.3B |
| UNHUNITEDHEALTH | $280.37 | -1.29% | -2.2% | 14.1x | 0.38 | $254.5B |
| AMGNAMGEN | $349.90 | -0.42% | -6.3% | 15.0x | 0.42 | $188.6B |
| ABTABBOTT | $107.19 | -1.12% | -4.5% | 17.2x | 0.74 | $186.3B |
| GILDGILEAD | $141.06 | -0.17% | -8.6% | 14.7x | 0.37 | $175.2B |
| TMOTHERMO | $470.21 | +1.18% | -6.2% | 17.5x | 0.97 | $174.7B |
Fundamentals
Market Cap$11.6B
P/E (TTM)7.6
Forward P/E9.5
Beta—
Div Yield—
Prev Close$67.27
RSI (14-Day)
23Oversold
0305070100
52-Week Range
$60.70$67.14$88.20
From High-23.9%
From Low+10.6%
Moving Averages
50d SMA
$75.43-11.0%
200d SMA
$75.11-10.6%
Price below 200d MA — bearish structure.
Returns
1W
+1.5%
1M
-10.4%
3M
-16.7%
6M
-9.4%
1Y
-10.8%
YTD
-15.0%
Volume
Today26K
20d Avg1.3M
Ratio0.02x